Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(7):493; doi:10.1093/jnci/djk167
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Savage, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Savage, L.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

MEMO TO THE MEDIA

Press Release

Combining Therapies Can Improve Survival for Early-Stage Breast Cancer Patients

Liz Savage

jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute

The first 10% of the full text of this article appears below.

Patients with early-stage breast cancer who are treated with both chemotherapy and tamoxifen have a higher survival rate than patients who receive only tamoxifen. But a combination of tamoxifen and ovarian suppression—treatment to stop the ovaries from functioning—did not show any additional benefits, according to two randomized clinical trials published in the April 4 Journal of the National Cancer Institute.

Survival . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing
Kathleen I. Pritchard
J Natl Cancer Inst 2007 99: 494-495. [Extract] [Full Text] [PDF]

Polychemotherapy for Early Breast Cancer: Results From the International Adjuvant Breast Cancer Chemotherapy Randomized Trial
The Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst 2007 99: 506-515. [Abstract] [Full Text] [PDF]

Ovarian Ablation or Suppression in Premenopausal Early Breast Cancer: Results From the International Adjuvant Breast Cancer Ovarian Ablation or Suppression Randomized Trial
The Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst 2007 99: 516-525. [Abstract] [Full Text] [PDF]